Mike Mitka. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Anemia/drug therapyDrug LabelingErythropoietin/therapeutic useHumansRecombinant ProteinsRiskUnited StatesUnited States Food and Drug Administration
Substances: See more » Recombinant ProteinsErythropoietin
Year: 2007 PMID: 17473287 DOI: 10.1001/jama.297.17.1868
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272